HER2-Positive Gastric Cancer Market: Current Analysis and Forecast (2023-2030)

Report Description

According to a new report by Univdatos Market Insights, HER2-Positive Gastric Cancer Market, is USD 200 Mn in 2022 by growing at a CAGR of 7%. The HER2-positive gastric cancer market is expected to grow significantly in the next few years, driven by the rising incidence and prevalence of gastric cancer, advances in targeted therapy, and the availability of effective treatments.

HER2-positive gastric cancer is a subtype of gastric cancer that arises from the cells lining the stomach and is characterized by the overexpression of the HER2 protein. This subtype accounts for approximately 20% of all gastric cancers and is more aggressive and less responsive to conventional therapies compared to HER2-negative gastric cancer. The market for HER2-positive gastric cancer treatments is expected to be driven by the growing demand for effective and affordable therapies for this subtype of gastric cancer. Advances in targeted therapy, such as HER2-directed therapies, have shown promising results in clinical trials and have become a standard of care for HER2-positive gastric cancer patients.

Some of the major players operating in the market include Roche, Eli Lilly and Company, Merck & Co., Bristol Myers Squibb, Pfizer, Novartis, Daiichi Sankyo, MacroGenics, Taiho Pharmaceutical, and Five Prime Therapeutics.

Insights Presented in the Report

“Amongst end-users, the Hospitals category is expected to dominate the market”

Based on end-users, the HER2-positive gastric cancer market is segmented into hospitals, specialty cancer centers, and others. Hospitals are often at the forefront of cancer treatment, providing a wide range of medical services and expertise. They have the advantage of offering comprehensive care, including surgery, chemotherapy, targeted therapy, and supportive care, all under one roof. Hospitals are the leading segment due to their accessibility, familiarity to patients, and the ability to provide a holistic approach to cancer management.

 “North America dominated the HER2-Positive Gastric Cancer Market in 2022”

North America dominated the HER2-Positive Gastric Cancer market in 2022. North America is expected to lead the HER2-positive gastric cancer market due to several factors, including the high prevalence of gastric cancer, the availability of advanced healthcare infrastructure, and the high healthcare expenditure in the region. For instance, according to the American Cancer Society, gastric cancer is the fifth most common cancer in the United States, with over 27,000 new cases diagnosed each year. Additionally, the availability of advanced healthcare infrastructure and the high healthcare expenditure in the region provide a favorable environment for the development and commercialization of HER2-positive gastric cancer treatments. Moreover, the presence of several leading biopharmaceutical companies with a strong pipeline of HER2-targeted therapies is responsible for the growth of the market in the region. For instance, Roche, which markets trastuzumab, and Pfizer, which markets lapatinib, have a strong presence in the region and are expected to continue to invest in the development of HER2-targeted therapies for gastric cancer.

HER2-Positive Gastric Cancer Market Report Coverage

Reasons to buy this report:

• The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
• The report presents a quick review of overall industry performance at one glance.
• The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolios, expansion strategies, and recent developments.
• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
• The study comprehensively covers the market across different segments.
• Deep dive regional level analysis of the industry.

Customization Options:

The global HER2-Positive Gastric Cancer market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

You can also purchase parts of this report. Do you want to check out a section wise
price list?

Get in touch with team

Research Methodology

Research Methodology for the HER2-Positive Gastric Cancer Market Analysis (2023-2030)

Analyzing the historical market, estimating the current market, and forecasting the future market of the global HER2-Positive Gastric Cancer market were the three major steps undertaken to create and analyze the adoption of HER2-Positive Gastric Cancer in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global HER2-Positive Gastric Cancer market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:

Analysis of Historical Market Size

Step 1: In-Depth Study of Secondary Sources:

Detail secondary study was conducted to obtain the historical market size of the HER2-Positive Gastric Cancer market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.

Step 2: Market Segmentation:

After obtaining the historical market size of the HER2-Positive Gastric Cancer market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as treatment type and end-users. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.

Step 3: Factor Analysis:

After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the HER2-Positive Gastric Cancer market. Further, we conducted factor analysis using dependent and independent variables such as treatment type and end-users of the HER2-Positive Gastric Cancer market. A thorough analysis was conducted of demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the HER2-Positive Gastric Cancer market sector across the globe.

Current Market Size Estimate & Forecast

Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global HER2-Positive Gastric Cancer market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.

Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2028 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:

• The industry’s market size, in terms of revenue (USD) and the adoption rate of the HER2-Positive Gastric Cancer market across the major markets domestically
• All percentage shares, splits, and breakdowns of market segments and sub-segments
• Key players in the global HER2-Positive Gastric Cancer market in terms of products offered. Also, the growth strategies adopted by these players to compete in the fast-growing market

Market Size and Share Validation

Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.

Split of Primary Participants in Different Regions

Market Engineering

The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global HER2-Positive Gastric Cancer market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of the treatment type and end-users in the global HER2-Positive Gastric Cancer market.

The main objective of the Global HER2-Positive Gastric Cancer Market Study

The current & future market trends of the global HER2-Positive Gastric Cancer market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:

• Analyze the current and forecast market size of the HER2-Positive Gastric Cancer market in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments
• Segments in the study include areas of the treatment type and end-users
• Define and analysis of the regulatory framework for the HER2-Positive Gastric Cancer industry
• Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry
• Analyze the current and forecast market size of the HER2-Positive Gastric Cancer market for the major region
• Major countries of regions studied in the report include Asia Pacific, Europe, North America, and the Rest of the World
• Company profiles of the HER2-Positive Gastric Cancer market and the growth strategies adopted by the market players to sustain in the fast-growing market
• Deep dive regional level analysis of the industry

You can also purchase parts of this report. Do you want to check out a section wise
price list?

Get in touch with team